{HEAD ~ The therapeutic compositions} can be and formulated to reduce {TAIL ~ the extent} of a Plasmodium infection in the recipient subject, or to reduce the likelihood of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject 
{ HEAD ~ The therapeutic compositions } can be and formulated to reduce { TAIL ~ the extent } of a Plasmodium infection in the recipient subject , or to reduce the likelihood of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject
HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH REL REL REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH